Table 1.

Demographics.

Patient Demographics	Baseline	Week 4	Week 8	Week 12	Week 16
Number of subjects: treatment (control)	62 (12)	59 (10)	54 (11)	51 (8)	40 (8)
Age range, y, median	31-73 (56)
Average reported symptomatic months	19.2
Gender, male/female	24/50